Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
7.58
+0.18 (2.43%)
At close: Apr 15, 2025, 4:00 PM
7.57
-0.01 (-0.13%)
After-hours: Apr 15, 2025, 7:43 PM EDT
Arvinas Employees
Arvinas had 430 employees as of December 31, 2024. The number of employees decreased by 15 or -3.37% compared to the previous year.
Employees
430
Change (1Y)
-15
Growth (1Y)
-3.37%
Revenue / Employee
$612,558
Profits / Employee
-$462,558
Market Cap
521.29M
Employees Chart
ARVN News
- 11 days ago - Arvinas Potential Parkinson's Treatment Shows Positive Data In Human Study - Benzinga
- 11 days ago - Arvinas Presents First-in-Human Data for Investigational Oral PROTAC ARV-102 Demonstrating Blood-Brain Barrier Penetration, and Central and Peripheral LRRK2 Degradation - GlobeNewsWire
- 19 days ago - Arvinas Announces Oral Presentation at 2025 International Conference on Alzheimer's & Parkinson's Diseases - GlobeNewsWire
- 20 days ago - Top 3 Health Care Stocks That Are Set To Fly This Month - Benzinga
- 5 weeks ago - Arvinas, Pfizer Breast Cancer Drug Fails To Show Progression-Free Survival Benefit In Trial - Benzinga
- 5 weeks ago - Arvinas-Pfizer's breast cancer treatment meets main goal in late-stage study - Reuters
- 5 weeks ago - Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical Trial - GlobeNewsWire
- 6 weeks ago - Arvinas to Participate in Upcoming Investor Conferences - GlobeNewsWire